Pro-Dex Stock Price, News & Analysis (NASDAQ:PDEX) $16.34 +0.18 (+1.11%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$16.14▼$16.5050-Day Range$14.63▼$18.6352-Week Range$14.51▼$19.68Volume7,064 shsAverage Volume3,188 shsMarket Capitalization$57.94 millionP/E Ratio19.22Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media About Pro-Dex Stock (NASDAQ:PDEX)Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Read More PDEX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDEX Stock News HeadlinesDecember 2, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)November 24, 2023 | americanbankingnews.comPro-Dex (NASDAQ:PDEX) Coverage Initiated by Analysts at StockNews.comDecember 3, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 14, 2023 | finance.yahoo.comHere’s Why You Should Consider Buying Pro-Dex (PDEX) SharesNovember 10, 2023 | morningstar.comPro-Dex Inc PDEXNovember 2, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsNovember 2, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000October 26, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastDecember 3, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. October 26, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastOctober 15, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 13, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 4, 2023 | morningstar.comNorth American Morning Briefing: S&P 500 Futures -2-August 7, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns Have Hit A WallJune 29, 2023 | finance.yahoo.comAt US$18.26, Is It Time To Put Pro-Dex, Inc. (NASDAQ:PDEX) On Your Watch List?June 5, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastJune 5, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastMay 30, 2023 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 23% CAGR over the last five yearsMay 4, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month ResultsApril 20, 2023 | seekingalpha.comPDEX Pro-Dex, Inc.March 31, 2023 | finance.yahoo.comOne Pro-Dex, Inc. (NASDAQ:PDEX) insider upped their stake by 36% in the previous yearFebruary 27, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns On Capital Not Reflecting Well On The BusinessFebruary 14, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 2nd Quarter Results and 2023 Growth Strategy with The Stock Day PodcastFebruary 2, 2023 | msn.comPro-Dex GAAP EPS of $0.24 misses by $0.05, revenue of $11.28M beats by $0.88MFebruary 2, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month ResultsJanuary 30, 2023 | seekingalpha.comPro-Dex Is Growing But Expensive Given Its RiskJanuary 20, 2023 | finance.yahoo.comWhy Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth WatchingSee More Headlines Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today12/03/2023Next Earnings (Estimated)2/01/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PDEX CUSIPN/A CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees145Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.85 Trailing P/E Ratio19.22 Forward P/E RatioN/A P/E GrowthN/ANet Income$7.07 million Net Margins6.56% Pretax Margin15.19% Return on Equity10.89% Return on Assets6.28% Debt Debt-to-Equity Ratio0.27 Current Ratio3.79 Quick Ratio1.83 Sales & Book Value Annual Sales$46.94 million Price / Sales1.23 Cash Flow$2.27 per share Price / Cash Flow7.21 Book Value$8.79 per share Price / Book1.86Miscellaneous Outstanding Shares3,547,000Free Float2,036,000Market Cap$57.94 million OptionableNot Optionable Beta0.79 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Richard Lee Van Kirk Jr. (Age 62)CEO, President, COO & Director Comp: $418.61kMs. Alisha K. Charlton (Age 53)CFO & Corporate Secretary Comp: $297.61kKey CompetitorsCarmellNASDAQ:CTCXCytosorbentsNASDAQ:CTSOInspireMDNYSE:NSPRIceCure MedicalNASDAQ:ICCMDelcath SystemsNASDAQ:DCTHView All CompetitorsInstitutional OwnershipAcadian Asset Management LLCSold 6,570 shares on 11/13/2023Ownership: 1.738%Punch & Associates Investment Management Inc.Bought 5,235 shares on 10/26/2023Ownership: 1.961%View All Institutional Transactions PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed in 2023? Pro-Dex's stock was trading at $15.90 at the beginning of the year. Since then, PDEX stock has increased by 2.7% and is now trading at $16.3357. View the best growth stocks for 2023 here. When is Pro-Dex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024. View our PDEX earnings forecast. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) announced its quarterly earnings results on Thursday, November, 2nd. The medical instruments supplier reported ($0.17) EPS for the quarter. The medical instruments supplier earned $11.94 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 10.89% and a net margin of 6.56%. What is Michael J. Berthelot's approval rating as Pro-Dex's CEO? 3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH). Who are Pro-Dex's major shareholders? Pro-Dex's stock is owned by a variety of retail and institutional investors. Top institutional investors include Punch & Associates Investment Management Inc. (1.96%) and Acadian Asset Management LLC (1.74%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Nicholas John Swenson and William James Farrell III. View institutional ownership trends. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:PDEX) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.